SCHEMBL14339705

SCHEMBL14339705

C=C[C@@H](C)c1c(OCc2ccc(OC)cc2)cccc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.47
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
KMT2A Q03164 1/20 0.47
TLR4 O00206 1/20 0.44
TLR2 O60603 1/20 0.44
HTR1A P08908 3/20 0.43
ADRA1D P25100 3/20 0.43
ADRA1A P35348 3/20 0.43
ADRA1B P35368 3/20 0.43
CYP19A1 P11511 2/20 0.41
ALDH1A1 P00352 3/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
FFAR1 O14842 1/20 0.40
DCTPP1 Q9H773 1/20 0.40
ABCB1 P08183 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4946688 0.85 SMN1; SMN2 (0.50) NPC1RAB9ASMN1; SMN2KMT2ATLR4
SCHEMBL20876320 0.77 NPC1 (0.54) NPC1RAB9ASMN1; SMN2KMT2ATLR4
SCHEMBL7976948 0.77 NPC1 (0.54) NPC1RAB9ASMN1; SMN2KMT2ATLR4
SCHEMBL4947178 0.74 SMN1; SMN2 (0.51) NPC1RAB9ASMN1; SMN2KMT2ATLR4
SCHEMBL2420234 0.74 NPC1 (0.53) NPC1RAB9ASMN1; SMN2KMT2ATLR4
SCHEMBL11145777 0.72 HTR1A (0.51) NPC1RAB9ASMN1; SMN2KMT2AHTR1A
SCHEMBL3099586 0.71 NPC1 (0.49) NPC1RAB9ASMN1; SMN2KMT2ATLR4
SCHEMBL11746120 0.70 CYP19A1 (0.48) NPC1RAB9ASMN1; SMN2KMT2ATLR4
SCHEMBL3873841 0.70 CYP19A1 (0.51) NPC1RAB9ASMN1; SMN2KMT2ATLR4
SCHEMBL30449234 0.70 CYP19A1 (0.51) NPC1RAB9ASMN1; SMN2KMT2ATLR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326856-B1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-BETA) INHIBITING ACTIVITY BAYER HEALTHCARE AG (DE) 2007-12-19 EP disclosed